我要投票 诺禾致源NOVOGENE在医疗器械行业中的票数:343
· 外 推 电 报 ·
2025-06-25 14:55:43 星期三

【诺禾致源NOVOGENE是哪个国家的品牌?】

诺禾致源NOVOGENE是什么牌子?「诺禾致源NOVOGENE」是 北京诺禾致源科技股份有限公司 旗下著名品牌。该品牌发源于北京,由创始人李瑞强在2011-03-15期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力诺禾致源NOVOGENE品牌出海!将品牌入驻外推网,定制诺禾致源NOVOGENE品牌推广信息,可以显著提高诺禾致源NOVOGENE产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

北京诺禾致源科技股份有限公司于2011年3月在北京中关村生命科学园注册成立,专注于开拓前沿分子生物学技术和高性能计算在生命科学研究和人类健康领域的应用,致力于成为全球领先的基因组学产品和服务提供者。企业总部位于北京,在天津、南京、美国和新加坡设有实验室或实验基地,并在香港、美国和英国设有子公司,办公面积逾26'000m2。

诺禾致源目前已经成为全球较大测序服务中心,每年可完成200'000人全基因组测序的超高通量。诺禾致源引入的测序平台包括10台PacBioSequel、25台HiSeqX、10台HiSeq2000/2500、4台MiSeq、1台HiSeq4000、4台NextSeq500和6台LifeIonProton(DA8600);而全球领先的高性能计算平台和数据中心运算能力达到了878Tflops,总内存368TB,总存储26.8PB,有效地支撑着生命科学研究和医疗健康两大领域对大数据分析和存储的需求。

目前,诺禾致源现已建立一支来自海内外顶级名校、多学科交叉型的高素质综合团队,其中硕士及其以上学历占比近68%。以创始人李瑞强博士为首建立的生物信息学专业分析团队以技术产品开发为导向,在分子病理学、肿瘤诊治和遗传病检测及大数据整合等多个层面积累了丰富的经验。

诺禾致源的业务覆盖科技服务、肿瘤基因检测及遗传检测等领域,为全球研究型大学、科研院所、医院、医药研发企业、农业企业等提供基因测序和生物信息技术支持等服务。肿瘤检测依托完整的分子病理检测平台,面向患者、医院和药企提供精准的实体瘤分子病理检测产品与服务,以深度基因测序和大数据分析解读为核心,持续开发国际领先的肿瘤基因检测产品,提供肿瘤用药指导、动态监测、肿瘤遗传易感基因检测等肿瘤精准治疗解决方案。在遗传检测方面诺禾致源已开发一系列基于二代测序技术的检测服务,包括孕前基因检测,新生儿基因筛查,个人基因组等产品,致力于开拓基因组学在人类健康领域的应用,专注于生殖健康和个人基因组领域,并为客户提供专业的遗传咨询服务。


英文翻译:Beijing Nuohe Zhiyuan Technology Co., Ltd. was registered and established in Zhongguancun Life Science Park in March 2011. It focuses on exploring the application of cutting-edge molecular biology technology and high-performance computing in the field of life science research and human health, and is committed to becoming a leading global provider of genomic products and services. Headquartered in Beijing, the company has laboratories or experimental bases in Tianjin, Nanjing, the United States and Singapore, and subsidiaries in Hong Kong, the United States and the United Kingdom, with an office area of more than 26'000m2. At present, Nuohe Zhiyuan has become the largest sequencing service center in the world, which can complete the ultra-high throughput sequencing of the whole genome of 200'000 people every year. The sequencing platform introduced by Nuohe Zhiyuan includes 10 pacbiosequels, 25 hiseqx, 10 hiseq2000 / 2500, 4 miseq, 1 hiseq4000, 4 nextseq500 and 6 lifeionproton (da8600); the world's leading high-performance computing platform and data center have computing power of 878tflops, total memory of 368tb, total storage of 26.8pb, which effectively supports life science research and medical health The demand of big data analysis and storage in large fields. At present, Nuohe Zhiyuan has established a high-quality comprehensive team from top universities at home and abroad, with a master's degree or above accounting for nearly 68%. The bioinformatics professional analysis team, led by the founder Dr. Li Ruiqiang, has accumulated rich experience in molecular pathology, tumor diagnosis and treatment, genetic disease detection, big data integration and many other layers, guided by technical product development. Nuohe Zhiyuan's business covers science and technology services, tumor gene detection, genetic detection and other fields, providing gene sequencing and bio information technology support services for global research universities, scientific research institutes, hospitals, pharmaceutical R & D enterprises, agricultural enterprises, etc. Tumor detection relies on a complete molecular pathology detection platform to provide patients, hospitals and pharmaceutical companies with accurate solid tumor molecular pathology detection products and services. With in-depth gene sequencing and big data analysis and interpretation as the core, it continues to develop internationally leading tumor gene detection products, providing tumor medication guidance, dynamic monitoring, tumor genetic susceptibility gene detection and other tumor precise treatment Solution. In terms of genetic testing, Nuohe Zhiyuan has developed a series of testing services based on second-generation sequencing technology, including pre pregnancy gene testing, newborn gene screening, personal genome and other products, committed to exploring the application of genomics in the field of human health, focusing on the field of reproductive health and personal genome, and providing professional genetic consulting services for customers.

本文链接: https://www.waitui.com/brand/d899c7460.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

梵想发布便携式私有云新品FX2510智能NAS,深度集成ChatGPT、Deepseek等模型

36氪获悉,近日,科技品牌梵想携覆盖消费级、工业级、AIoT生态的全域存储解决方案亮相2025年巴西圣保罗消费电子及家电展览会(Eletrolar Show Brazil 2025)。会上,梵想发布便携式私有云新品FX2510智能NAS,全面升级后的FX2510已深度集成ChatGPT、Deepseek、豆包等10余个主流AI模型接口,实现文本、语音、图像等多模态数据的智能识别与跨平台交互,让便携NAS具备“边存边用、边存边思考”的能力。

56分钟前

英特尔将关停汽车业务?回应:逐步收缩,将确保客户顺利过渡

据外媒报道,英特尔将关闭其小型汽车业务,并解雇该领域的大多数员工,这是其大幅裁员的最新举措。据悉,目前有5000万辆汽车使用英特尔处理器。目前,英特尔方面已确认了调整一事,并回应称:“正如此前宣布的,我们正在重新聚焦战略重心,强化核心客户端与数据中心产品组合和业务,以满足客户的需求。作为这项计划的一部分,我们决定逐步收缩客户端计算事业部旗下的汽车业务。”(新浪财经)

56分钟前

新东方集思未来在苏州等成立智能科技公司,含AI软件开发业务

36氪获悉,爱企查App显示,近日,苏州新集思未来智能科技有限公司成立,法定代表人为颜盛,注册资本1000万元人民币,经营范围包括计算机系统服务、人工智能应用软件开发、教育咨询服务、电子元器件制造等。股权穿透图显示,该公司由苏州尚莱科技合伙企业(有限合伙)、北京集思互联教育科技有限公司、新东方教育科技集团有限公司旗下北京东方卓永投资管理有限公司、苏州太元合一资产投资有限公司共同持股。

56分钟前

韩国5月零售销售同比增长7%,线下零售额四个月来首次增长

韩国产业通商资源部周三公布的数据显示,受高价值产品需求强劲的推动,韩国零售商5月份的线下销售额四个月以来首次出现增长。上个月,主要线下零售公司的销售额同比增长0.9%,结束了连续三个月的同比下降,而主要在线平台的销售额增长了13%。线下和线上零售商的总销售额同比增长了7%。韩国产业通商资源部将线下销售的增长归因于消费者价格的上涨和对高价商品的强劲需求。(新浪财经)

56分钟前

沪指创年内新高

36氪获悉,截至发稿,午后指数持续走强,沪指涨0.6%,创下年内新高;创业板指拉升涨近2%,深成指拉升涨近1%。大金融、军工、半导体芯片、数字货币等方向涨幅居前,沪深京三市上涨个股近2900。

56分钟前

本页详细列出关于诺禾致源NOVOGENE的品牌信息,含品牌所属公司介绍,诺禾致源NOVOGENE所处行业的品牌地位及优势。
咨询